6533b828fe1ef96bd1287b98

RESEARCH PRODUCT

The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study

James B. KirkbrideHannah E. JongsmaAlastair G. CardnoPaulo Rossi MenezesAndrea QuattronePierre-michel LlorcaJose Luis SantosIlaria TarriconeF. SeminerioCharlotte Gayer-andersonLucia SideliRoberto MuratoriDaniele La BarberaG TripoliTeresa Sánchez-gutiérrezJim Van OsJim Van OsBart P. F. RuttenMiguel BernardoMarta Di FortiMarta Di FortiRobin M. MurrayRobin M. MurraySarah TosatoJulio SanjuánLieuwe De HaanManuel ArrojoCrocettarachele SartorioEva VelthorstEva VelthorstAndrei SzökeAntonio LasalviaJulio BobesDiego QuattroneDiego QuattroneDiego QuattroneCraig MorganUlrich ReininghausUlrich ReininghausUlrich ReininghausVictoria RodriguezEvangelos VassosJean-paul SeltenGiovanna MarrazzoCaterina La CasciaCelso ArangoCristina Marta Del-benAndrea TortelliLaura FerraroPeter B. Jones

subject

PsychosisFirst episode psychosiscognitive domainsPremorbid Adjustment ScaleQUOCIENTE DE INTELIGÊNCIATransdiagnostic Premorbid adjustmentNEGATIVE SYMPTOMSArticlesymptom dimensionspremorbid adjustmentWORKING-MEMORYSecondary analysisFirst episode psychosisfirst episode psychosis1ST-EPISODE NONAFFECTIVE PSYCHOSISMedicineScopusCognitive domain[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Settore MED/25 - PsichiatriaBiological PsychiatryTransdiagnosticbusiness.industryWorking memoryConfoundingCognitive domainsCognitionBIPOLAR DISORDERSymptom dimensionsmedicine.diseaseGENE-ENVIRONMENT INTERACTIONSFirst episode psychosiCANNABIS USEPsychiatry and Mental healthSymptom dimensionPerceptual reasoningJCRIQSOCIAL COGNITIONtransdiagnosticPROCESSING-SPEEDNEURODEVELOPMENTAL TRAJECTORIES[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Premorbid adjustmentbusinessSCHIZOAFFECTIVE DISORDERClinical psychology

description

Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid adjustment with symptom dimensions in a large first episode psychosis (FEP) sample. We used data from the international EU-GEI study. Bifactor modelling of the Operational Criteria in Studies of Psychotic Illness (OPCRIT) ratings provided general and specific symptom dimension scores. Premorbid Adjustment Scale estimated premorbid social (PSF) and academic adjustment (PAF), and WAIS-brief version measured IQ. A MANCOVA model examined the relationship between symptom dimensions and PSF, PAF, and IQ, having age, sex, country, self-ascribed ethnicity and frequency of cannabis use as confounders. In 785 patients, better PSF was associated with fewer negative (B=-0.12, 95% C.I. -0.18, -0.06, p<0.001) and depressive (B=-0.09, 95% C.I. -0.15, -0.03, p=0.032), and more manic (B=0.07, 95% C.I. 0.01, 0.14, p=0.023) symptoms. Patients with a lower IQ presented with slightly more negative and positive, and fewer manic, symptoms. Secondary analysis on IQ subdomains revealed associations between better perceptual reasoning and fewer negative (B=-0.09, 95% C.I. -0.17, -0.01, p=0.023) and more manic (B=0.10, 95% C.I. 0.02, 0.18, p=0.014) symptoms. Fewer positive symptoms were associated with better processing speed (B=-0.12, 95% C.I. -0.02, -0.004, p=0.003) and working memory (B=-0.10, 95% C.I. -0.18, -0.01, p=0.024). These findings suggest that the negative and manic symptom dimensions may serve as clinical proxies of different neurodevelopmental predisposition in psychosis.

10.1016/j.schres.2021.08.008https://cris.maastrichtuniversity.nl/en/publications/4765bcb3-c840-41c7-87ab-0ab6dd1ddb6c